Navigation Links
The Academy of Nutrition and Dietetics advocates for expanded nutritional coverage under Medicare
Date:12/18/2011

Philadelphia, PA -- The Academy of Nutrition and Dietetics has prepared a request to submit to the Centers for Medicare and Medicaid Services (CMS) to expand coverage of medical nutrition therapy (MNT) for specific diseases, including hypertension, obesity, and cancer, as part of the CMS National Coverage Determination (NCD) Process. Most chronic health conditions can be controlled or treated with medical nutrition therapy, yet Medicare will only reimburse nutrition therapy services provided by a registered dietitian for individuals with diabetes and renal disease. "That's just not enough if we want to improve the health of the nation and rein in escalating healthcare costs," says Marsha Schofield, MS, RD, LD, the Academy's Director of Nutrition Services Coverage.

Under the NCD Process, the Secretary of the Department of Health and Human Services can expand Medicare coverage for services that are reasonable and necessary for the prevention of an illness. Ms. Schofield explains, "There are an escalating number of baby boomers turning 65 and entering the Medicare system. The majority of Medicare spending is on individuals with chronic conditions, and almost 70% of Medicare beneficiaries suffer from cardiovascular disease. Chronic conditions can be controlled or treated with medical nutrition therapy, so it just makes sense to try to expand the Medicare beneficiary's access to these important services."

The Academy's NCD request is published in the January 2012 issue of the Journal of the Academy of Nutrition and Dietetics and it presents evidence from over 20 scientific studies that demonstrate the health benefits and cost effectiveness of medical nutrition therapy, provided by registered dietitians, in older adults with several diseases and conditions. The evidence is grouped into three sections: cardiovascular disease, including the treatment of high cholesterol, hypertension, and heart failure; disease progression, including o
'/>"/>

Contact: Eileen Leahy
adajmedia@elsevier.com
732-238-3628
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Academy participates in project to discover drugs, biofuels in tropical seas
2. NWO and Academy launch research program with China
3. Carnegies Doug Koshland elected Fellow of the American Academy of Microbiology
4. University of Texas at Austin engineer elected to American Academy of Arts and Sciences
5. MBL director and CEO and cell biology pioneer Gary Borisy elected to National Academy of Sciences
6. Swine flu experts gather at New York Academy of Sciences May 28
7. Singapore scientists elected into National Academy of Sciences
8. Seventy-three scientists elected to the American Academy of Microbiology
9. New species of phallus-shaped mushroom named after California Academy of Sciences scientist
10. Academy Library accepted to prestigious Biodiversity Heritage Library
11. US National Academy of Sciences wins 2009 CAAT recognition award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/5/2015)... 2015 According to a new ... Software, Services, Vertical (BFSI, Airport, IT & Telecom, Utilities, ... Forecast to 2020", published by MarketsandMarkets, defines and segments ... various segments. The global PIAM Market is estimated to ... by 2019, at a CAGR of 14.9 % from ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... which trauma and burn patients are most likely to ... range of experimental clinical settings ?an important hurdle to ... rooms and intensive care units. , In a report ... National Academy of Sciences, researchers from eight institutions, including ...
... of California, San Diego (UCSD) have found that Lafora disease, ... the age of 30, can be caused by mutations in ... These findings are reported in the current issue of Proceedings ... is characterized by normal development for the first decade of ...
... comparing, for the first time, breast cancers from Nigeria, ... African ancestry are more likely to be diagnosed with ... of European ancestry. , Researchers from the University of ... in Nigeria and the University of North Carolina, found ...
Cached Biology News:Doctors closer to using gene analysis to help trauma patients 2Doctors closer to using gene analysis to help trauma patients 3UCSD research reveals mechanism involved with type of fatal epilepsy 2Study reveals dramatic difference between breast cancers in US and Africa 2Study reveals dramatic difference between breast cancers in US and Africa 3Study reveals dramatic difference between breast cancers in US and Africa 4
(Date:8/31/2015)... BALTIMORE , Aug. 31, 2015  For people ... may brighten their day. The biotechnology company, located in ... outlined one of the best potential therapies yet for ... paper entitled, " Correction of Down syndrome and Edwards ... the journal DNA Research . Elixirgen plans to ...
(Date:8/31/2015)... HAYWARD, Calif. and SHANGHAI ... Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, ... Phase 2 clinical study for its lead drug ... designed to treat drug-resistant bacteria such as MRSA ... safer and better tolerated therapeutic option than currently ...
(Date:8/31/2015)... ... August 31, 2015 , ... Regulatory agencies have acknowledged ... development approval process. Thus, innovator companies must understand what will be needed in ... CMO, has been hosting multiple educational panels and seminars for experts to share ...
(Date:8/30/2015)... , England , August 31, ... beendet die 51-jährige Wartezeit   einer Frau   für ... Frauen im Alter von 7-90   werden ... Programm soll 1200 Frauen behandeln und die ... , Astellas gab heute bekannt, ...
Breaking Biology Technology:New Down syndrome therapy discovered 2MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5
... Colo., Sept. 25 Steve Pettit, Director of,the ... http://www.InVitria.com ) Cellastim in mammalian cell culture at ... week., "Cellastim showed superior results compared to ... 50% improvement in productivity in CHO cell,lines using ...
... in Complement Inhibition and,Impact of Soliris on Patients ... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) has ... Biotechnology Product for Soliris(R) (eculizumab). The Award,recognizes the ... and the impact the drug is,having on the ...
... Net Income of $27 to $28 ... ... Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), ... China ("PRC"), today announced that it,has increased its revenue and earnings guidance ...
Cached Biology Technology:InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 3Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 4Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 5China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3
...
... Suite for Mac OS X provides the ... and protein sequence analysis and molecular biology ... (Table 1). With Vector NTI Suite you ... and publicize diverse types of molecular biology ...
...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Biology Products: